Articles

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

Mayo Clinic, Scottsdale, AZ, USA
Hôpital Saint-Louis et Université Paris Diderot, Paris, France
The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
University of Leipzig, Germany
Stanford Cancer Institute, Stanford, CA, USA
Medical University of Vienna, Austria
Incyte Corporation, Wilmington, DE, USA
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Washington University School of Medicine, St. Louis, MO, USA
Novartis Pharma, Basel, Switzerland
Frankston Hospital and Monash University, Frankston, Victoria, Australia
Incyte Corporation, Wilmington, DE, USA
Cliniques Universitaires Saint-Luc, Université Catholique de Louvain and Ludwig Institute for Cancer Research, Brussels, Belgium
Oregon Health and Science University, Portland, OR, USA
Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Saint Agnes Cancer Institute, Baltimore, MD, USA
University of Florence, Florence, Italy
Weill Cornell Medical College, New York, NY, USA
A.O. Ospedali Riuniti di Bergamo, Italy
University of Michigan, Ann Arbor, MI, USA
IRCCS Policlinico San Matteo Foundation, Pavia, Italy
Emory University School of Medicine, Atlanta, GA, USA
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Birmingham Hematology and Oncology, Birmingham, AL, USA
Duke University Health System, Durham, NC, USA
Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA
Cancer Care Centers of South Texas and US Oncology, San Antonio, TX, USA
UCLA Division of Hematology and Oncology, Los Angeles, CA, USA
Columbia Presbyterian Medical Center, New York, NY, USA
Incyte Corporation, Wilmington, DE, USA
Incyte Corporation, Wilmington, DE, USA
The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
Guy’s and St. Thomas’ NHS Foundation Trust, Guy’s Hospital, London, UK
Vol. 99 No. 2 (2014): February, 2014 https://doi.org/10.3324/haematol.2013.087650